Denis Drygin
Branden Ryu
Branden Ryu is the founder, the chief executive officer, and the chairman of BIORCHESTRA.
Branden earned his Ph.D. degree from the Graduate school of medicine at the University of Tokyo and completed the Harvard MIT health science and technology internship program at MGH. Also, he has experience as a researcher at Harvard medical school.
After his research career, he found BIORCHESTRA to focus on developing RNA-based therapeutics in 2016. He has discovered the novel RNA biomarker and invented the novel ASO modality to treat neurodegenerative diseases. Under his leadership, BIORCHESTRA has expanded the new RNA modalities to cure neurological disorders including genetic rare diseases. Based on these scientific results, he has filed more than 70 patent applications since 2017.
Armon Sharei
Anisha D'Souza
Andrew Geall
Andrew Tsonchev
Patrick Bayle
Patrick Bayle is a CISM CISSP, Senior Systems Engineer at Cortex, who spent the first ten years of his career working on the security front lines for one of the largest financial institutions in the world.
Tim Erridge
Unit 42 Vice President Tim Erridge is a highly accomplished cybersecurity innovator who is a recognized expert in driving pragmatic solutions that enable global organizations to protect their networks and data amid today’s faster-than-ever-evolving threat landscape. For more than two decades, he has advocated and advanced intelligence-led cybersecurity strategy and operational programmes across a variety of industries and within large, complex multinationals. A distinguished thought leader in cybersecurity, he frequently shares his insights at industry events and in whitepapers and publications.
